Evidence map›Paper›PMID 32265325›Full record

ArticlemBio2020

Multiplex Genetic Engineering Exploiting Pyrimidine Salvage Pathway-Based Endogenous Counterselectable Markers.

Lukas Birštonas, Alex Dallemulle, Manuel S López-Berges, Ilse D Jacobsen, Martin Offterdinger, Beate Abt, Maria Straßburger, Ingo Bauer, Oliver Schmidt, Bettina Sarg and 3 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Shining a light on the impact of antifungals onAntimicrobial agents and chemotherapy · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Characterization and engineering of the xylose-inducibleMetabolic engineering communications · 2022
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Inducible Selectable Marker Genes to ImproveJournal of fungi (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Lukas BirštonasInstitute of Molecular Biology/Biocenter, Innsbruck Medical University, Innsbruck, Austria.
Alex DallemulleInstitute of Molecular Biology/Biocenter, Innsbruck Medical University, Innsbruck, Austria.
Manuel S López-BergesInstitute of Molecular Biology/Biocenter, Innsbruck Medical University, Innsbruck, Austria.
Ilse D JacobsenResearch Group Microbial Immunology, Leibniz Institute for Natural Product Research and Infection Biology-Hans Knöll Institute, Jena, Germany.
Martin OffterdingerInstitute of Neurobiochemistry/Biocenter, Innsbruck Medical University, Innsbruck, Austria.
Beate AbtInstitute of Molecular Biology/Biocenter, Innsbruck Medical University, Innsbruck, Austria.
Maria StraßburgerTransfer Group of Antiinfectives, Leibniz Institute for Natural Product Research and Infection Biology-Hans Knöll Institute, Jena, Germany.
Ingo BauerInstitute of Molecular Biology/Biocenter, Innsbruck Medical University, Innsbruck, Austria.ORCID 0000-0002-3316-7769
Oliver SchmidtInstitute of Cell Biology/Biocenter, Innsbruck Medical University, Innsbruck, Austria.
Bettina SargInstitute of Clinical Biochemistry/Biocenter, Innsbruck Medical University, Innsbruck, Austria.
Herbert LindnerInstitute of Clinical Biochemistry/Biocenter, Innsbruck Medical University, Innsbruck, Austria.
Hubertus HaasInstitute of Molecular Biology/Biocenter, Innsbruck Medical University, Innsbruck, Austria.
Fabio GsallerInstitute of Molecular Biology/Biocenter, Innsbruck Medical University, Innsbruck, Austria fabio.gsaller@i-med.ac.at.
Innsbruck Medical University · ATLeibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI) · DE

Funding

Austrian Science Fund FWF P 31093
6 · The paper itself

Abstract

Selectable markers are indispensable for genetic engineering, yet their number and variety are limited. Most selection procedures for prototrophic cells rely on the introduction of antibiotic resistance genes. New minimally invasive tools are needed to facilitate sophisticated genetic manipulations. Here, we characterized three endogenous genes in the human fungal pathogen

Indexed as

Mutagenesis, InsertionalAnimalsAnti-Bacterial AgentsAspergillosisAspergillus fumigatusFemaleFusariumGenetic EngineeringGenetic MarkersHumansMicePenicillium chrysogenumPyrimidinesSpecific Pathogen-Free OrganismsAnti-Bacterial AgentsGenetic MarkersPyrimidinesendogenous selectable markersgenetic engineeringpyrimidine salvage pathwaytargeted genomic integrations

Identifiers

PMID32265325
PMCPMC7157766
OpenAlexW3015146687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.